Similar articles

• Characteristics of Circulating Immune Complexes in HIV-Infected Patients with Different Viral Load.

  Korolevskaya LB, Shmagel KV, Shmagel NG. Korolevskaya LB, et al. Bull Exp Biol Med. 2015 Aug;159(4):469-71. doi: 10.1007/s10517-015-2994-6. Epub 2015 Sep 21. Bull Exp Biol Med. 2015. PMID: 26388572
• Increased immunoglobulin G, but not M, binding to endogenous retroviral antigens in HIV-1 infected persons.

  Lawoko A, Johansson B, Rabinayaran D, Pipkorn R, Blomberg J. Lawoko A, et al. J Med Virol. 2000 Dec;62(4):435-44. doi: 10.1002/1096-9071(200012)62:4<435::aid-jmv7>3.0.co;2-r. J Med Virol. 2000. PMID: 11074471
• Antiretroviral therapy-induced functional modification of IgG4 and IgM responses in HIV-1-infected individuals screened by an allosteric biosensor.

  Ferraz RM, Martínez MA, Cubarsi R, Villaverde A. Ferraz RM, et al. J Biomol Screen. 2008 Sep;13(8):817-21. doi: 10.1177/1087057108323126. Epub 2008 Aug 15. J Biomol Screen. 2008. PMID: 18708531
• Human IgM antibody therapy for HIV-1 infection.

  Okada N, Okada H. Okada N, et al. Microbiol Immunol. 1999;43(8):729-36. doi: 10.1111/j.1348-0421.1999.tb02463.x. Microbiol Immunol. 1999. PMID: 10524789 Review. No abstract available.
• Role of neutralizing antibodies in HIV infection.

  Haigwood NL, Stamatatos L. Haigwood NL, et al. AIDS. 2003;17 Suppl 4:S67-71. doi: 10.1097/00002030-200317004-00008. AIDS. 2003. PMID: 15080182 Review. No abstract available.